A new blood test developed by Israeli doctors has the potential to save many lives, as it will be able to test for diabetes, multiple sclerosis, pancreatic cancer, pancreatitis, and brain damage - all at once.
An Israeli-led international team of researchers has proof of concept for a single blood test that can detect multiple conditions, including diabetes, cancer, traumatic injury and neurodegeneration, in a highly sensitive and specific manner.
“Our work demonstrates that the tissue origins of circulating DNA can be measured in humans. This represents a new method for sensitive detection of cell death in specific tissues, and an exciting approach for diagnostic medicine,” said Dr. Ruth Shemer of the Hebrew University, a DNA methylation expert and one of the lead authors of the study.
The approach could offer a minimally invasive window for monitoring and diagnosing a broad spectrum of human pathologies, as well as providing a better understanding of normal tissue dynamics.